Journal of Cardiac Failure

Papers
(The H4-Index of Journal of Cardiac Failure is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Outcomes Of Hospitalization In Patients With Diastolic Heart Failure Undergoing Hematopoietic Stem Cell Transplant (HSCT): A National Inpatient Sample Analysis (2002-2019)504
Electrolyte Variability During Acute Decompensated Heart Failure Hospitalization299
Efficacy And Safety Of Intravenous Iron In Patients With Iron Deficiency Anemia And Heart Failure With Reduced Ejection Fraction. A Systematic Review And Meta-analysis192
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions137
Proteomic Correlates Of Urinary Protein Creatinine Ratio In Heart Failure With Preserved Ejection Fraction130
Psoas Muscle Index As An Independent Risk Factor Predictive Of Increased Post Operative Length Of Stay In Orthotopic Heart Transplant Candidates124
Prognostic Value Of Percentage Of Predicted Peak Oxygen Consumption Using Functional Aerobic Impairment And Friend Equations In Patients With Heart Failure With Reduced Ejection Fraction83
Effect Of Mavacamten On Echocardiographic Parameters In Patients With Obstructive Hypertrophic Cardiomyopathy: A Real World Cohort81
Readmission Rate And Hospitalization Costs In HFpEF In Patients With OSA78
Methodological Quality Of Clinical Practice Guidelines In Heart Failure: A Systematic Critical Appraisal Using The Agree II Tool66
Synchronized Diaphragmatic Stimulation As A Potential Outpatient Implant Procedure For HfrEF Therapy64
A Resident-led Initiative To Improve Heart Failure Readmission Rate By Targeting Factors Of Social Vulnerability55
Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management55
JCF Heart Failure Year-In-Review 2023… Shaping the Future of Heart Failure54
From Inflammation to Inspiration and Innovation: A New Perspective on the Utility of Anti-inflammatory Therapies for Acute Heart Failure53
Improving ATTR-CM Detection: Targeting Populations With the Greatest Need52
Higher ECMO Flow Index And Hyperoxia Are Associated With Increased Mortality In Adults With Cardiogenic Shock Receiving Venoarterial Extracorporeal Membrane Oxygenation: An ELSO Registry Analysis49
Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis49
Masthead48
Development And Implementation Of An Rv Stress Test To Assess Rv Reserve Pre-lvad48
The Swan is not the Ugly Duckling46
COUNTERPOINT: Abandon or Reassess? Interpreting Treatment Effects in “Negative” Clinical Trials44
Younger Adults Have Discordant Heart Failure Symptoms43
Durable Mechanical Circulatory Support: The Spring of Hope or the Winter of Despair?42
QT Interval Correction In Left Bundle Branch Areas Pacing (LBBAP)39
PHOSPHOPROTEOMIC INSIGHTS INTO PATHOBIOLOGY AND POTENTIAL DRUG TARGETS IN A PORCINE MODEL OF EXPERIMENTALLY INDUCED PULMONARY VENOUS HYPERTENSION38
Outcomes In Patients With Right Ventricular Failure & Preserved Left Ventricular Systolic Function On Short-term Inotropic Support37
Cardiovascular Interplay Between Heart Failure Patients With Concurrent Depression, A Comprehensive Retrospective Analysis37
Ventricular Assisted Device In Transposition Of Great Arteries: Indications, Outcomes, Hemodynamic Insights36
Cardiac Magnetic Resonance In Patients With Suspectedtachycardia-induced Cardiomyopathy - The Impact Of Lategadolinium Enhancement And Epicardial Fat Tissue36
Association Of Amiodarone With Rvf Post Lvad36
Emerging Adults: a Group Caught in the Middle35
Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF34
Novel FIRE1 Inferior Vena Cava Sensor Effective In Tracking And Managing Fluid Shifts In A Heart Failure Patient33
0.10172295570374